# Safety and Efficacy of Vagus Nerve Stimulator in Patients With Rheumatoid Arthritis (RA)

> **NCT03437473** · NA · COMPLETED · sponsor: **SetPoint Medical Corporation** · enrollment: 14 (actual)

## Conditions studied

- Rheumatoid Arthritis

## Interventions

- **DEVICE:** SetPoint Medical Neurostimulation of the Cholinergic Anti-inflammatory Pathway System

## Key facts

- **NCT ID:** NCT03437473
- **Lead sponsor:** SetPoint Medical Corporation
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-03-06
- **Primary completion:** 2018-12-10
- **Final completion:** 2018-12-10
- **Target enrollment:** 14 (ACTUAL)
- **Last updated:** 2018-12-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03437473

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03437473, "Safety and Efficacy of Vagus Nerve Stimulator in Patients With Rheumatoid Arthritis (RA)". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT03437473. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*